JGIA
CL icon

Jackson Grant Investment Advisers’s Colgate-Palmolive CL Stock Holding History

Jackson Grant Investment Advisers’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$475K Buy
5,577
+13
+0.2% +$1.16K 0.16% 75
2025
Q4 		$440K Sell
5,564
-693
-11% -$54.3K 0.14% 80
2025
Q3 		$500K Buy
6,257
+19
+0.3% +$1.62K 0.17% 75
2025
Q2 		$567K Buy
6,238
+19
+0.3% +$1.74K 0.21% 62
2025
Q1 		$583K Buy
6,219
+17
+0.3% +$1.52K 0.23% 60
2024
Q4 		$564K Buy
6,202
+17
+0.3% +$1.62K 0.22% 60
2024
Q3 		$642K Buy
6,185
+16
+0.3% +$1.63K 0.24% 60
2024
Q2 		$599K Sell
6,169
-325
-5% -$30K 0.24% 63
2024
Q1 		$585K Buy
6,494
+26
+0.4% +$2.2K 0.24% 60
2023
Q4 		$516K Buy
6,468
+27
+0.4% +$2.03K 0.23% 62
2023
Q3 		$458K Buy
6,441
+28
+0.4% +$2.09K 0.22% 61
2023
Q2 		$494K Buy
6,413
+25
+0.4% +$1.94K 0.23% 63
2023
Q1 		$480K Buy
6,388
+28
+0.4% +$2.08K 0.23% 63
2022
Q4 		$501K Buy
6,360
+27
+0.4% +$2.02K 0.24% 61
2022
Q3 		$445K Buy
6,333
+25
+0.4% +$1.96K 0.23% 60
2022
Q2 		$506K Sell
6,308
-533
-8% -$41.7K 0.25% 59
2022
Q1 		$519K Buy
6,841
+39
+0.6% +$3.09K 0.22% 61
2021
Q4 		$581K Buy
6,802
+38
+0.6% +$2.97K 0.3% 46
2021
Q3 		$511K Buy
6,764
+38
+0.6% +$3.02K 0.23% 59
2021
Q2 		$547K Buy
6,726
+37
+0.6% +$3.02K 0.24% 56
2021
Q1 		$527K Buy
6,689
+37
+0.6% +$2.9K 0.24% 57
2020
Q4 		$569K Buy
6,652
+34
+0.5% +$2.81K 0.29% 48
2020
Q3 		$511K Buy
6,618
+38
+0.6% +$2.9K 0.31% 46
2020
Q2 		$482K Buy
6,580
+42
+0.6% +$2.98K 0.31% 49
2020
Q1 		$434K Sell
6,538
-18
-0.3% -$1.27K 0.32% 48
2019
Q4 		$451K Buy
6,556
+42
+0.6% +$2.86K 0.24% 54
2019
Q3 		$479K Buy
6,514
+39
+0.6% +$2.83K 0.27% 50
2019
Q2 		$464K Buy
6,475
+40
+0.6% +$2.84K 0.27% 50
2019
Q1 		$441K Sell
6,435
-779
-11% -$50.3K 0.26% 51
2018
Q4 		$429K Buy
7,214
+44
+0.6% +$2.75K 0.3% 46
2018
Q3 		$480K Buy
7,170
+41
+0.6% +$2.73K 0.3% 47
2018
Q2 		$462K Sell
7,129
-18
-0.3% -$1.18K 0.32% 47
2018
Q1 		$512K Buy
7,147
+41
+0.6% +$2.95K 0.36% 40
2017
Q4 		$536K Buy
7,106
+38
+0.5% +$2.77K 0.36% 43
2017
Q3 		$515K Buy
7,068
+40
+0.6% +$2.88K 0.37% 40
2017
Q2 		$521K Buy
7,028
+35
+0.5% +$2.6K 0.4% 36
2017
Q1 		$512K Buy
6,993
+37
+0.5% +$2.59K 0.41% 35
2016
Q4 		$455K Buy
6,956
+35
+0.5% +$2.4K 0.39% 38
2016
Q3 		$513K Buy
6,921
+36
+0.5% +$2.66K 0.42% 35
2016
Q2 		$504K Buy
6,885
+37
+0.5% +$2.63K 0.44% 33
2016
Q1 		$484K Buy
6,848
+879
+15% +$58.5K 0.44% 35
2015
Q4 		$398K Buy
+5,969
New +$397K 0.38% 42

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jackson Grant Investment Advisers's CL Position: Q1 2026 in Review

Jackson Grant Investment Advisers increased its Colgate-Palmolive (CL) stake by 0.23% in Q1 2026, buying an estimated $1.16K and bringing the position to 5,577 shares worth $475K. The position accounts for 0.16% of the portfolio, ranked #75.

Jackson Grant Investment Advisers first reported a position in CL in Q4 2015 and has held it in 42 quarters since. The position peaked at $642K in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Jackson Grant Investment Advisers held 5,577 shares of Colgate-Palmolive worth $475K as of Q1 2026.
  • Jackson Grant Investment Advisers bought 13 Colgate-Palmolive shares in Q1 2026, an estimated $1.16K.
  • Colgate-Palmolive made up 0.16% of Jackson Grant Investment Advisers's portfolio in Q1 2026, its #75 holding.
  • Jackson Grant Investment Advisers first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 42 quarters since.
  • Jackson Grant Investment Advisers's Colgate-Palmolive position peaked at $642K in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q1 2026, filed 8 May 2026.